While all of the mechanisms by which GLP-1 agonists assist with weight loss are not yet fully understood, below are the well-established ways in which these injectable medications can contribute to weight loss: GLP-1s slow the release of glucagon and stimulate the secretion of insulin, thereby keeping blood sugar low
Vitamina B12, L-Carnitina, estimulante energtico
Commonly reported side effects include: Nausea Diarrhea Vomiting Constipation Stomach pain Decreased appetite Headache In rare cases, more serious side effects can occur, including pancreatitis, gallbladder problems, kidney injuries often related to dehydration from nausea or vomiting, serious allergic reactions, and changes in vision for type 2 diabetes patients
View on PubMed Retatrutide in Type 2 Diabetes with Inadequate Glycaemic Control: Phase 3 Trial (TRANSCEND-T2D-1) Phase 3 double-blind RCT confirming retatrutide produces significant HbA1c reduction and body weight loss in adults with type 2 diabetes, establishing its dual metabolic benefit across glycaemic control and body composition in a large clinical trial (Lancet, 2026)
Butler AE, Campbell-Thompson M, Gurlo T, Dawson DW, Atkinson M, and Butler PC
We recommend semaglutide for patients who need help jump-starting their weight-related lifestyle changes and turning healthy habits into daily routines